{{Rsnum
|rsid=2412541
|Gene=CASC5
|Chromosome=15
|position=40621642
|Orientation=plus
|ReferenceAllele=G
|MissenseAllele=T
|GMAF=0.3416
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=CASC5
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 26.5 | 71.7
| HCB | 50.4 | 42.9 | 6.8
| JPT | 43.6 | 45.5 | 10.9
| YRI | 9.6 | 32.9 | 57.5
| ASW | 7.0 | 38.6 | 54.4
| CHB | 50.4 | 42.9 | 6.8
| CHD | 42.6 | 44.4 | 13.0
| GIH | 8.9 | 46.5 | 44.6
| LWK | 11.9 | 39.4 | 48.6
| MEX | 21.4 | 53.6 | 25.0
| MKK | 4.5 | 40.4 | 55.1
| TSI | 3.9 | 18.6 | 77.5
| HapMapRevision=28
}}

{{Venter SNP
|rsid=2412541
|allele=T
|frequency=0.892
|uid=1103645593459
|type=homozygous_SNP
|hugo=CASC5
|ensembl gene=ENSG00000137812
|ensembl transcript=ENST00000346991
|sift=TOLERATED
|disease=A chromosomal aberration involving CASC5 is associated with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14) with MLL/HRX. May give rise to a MLL-CASC5 fusion protein.
}}

{{ neighbor
| rsid = 11858113
| distance = 337
}}

{{GET Evidence
|gene=CASC5
|aa_change=Ala486Ser
|aa_change_short=A486S
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2412541
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=0
|n_articles_annotated=0
|nblosum100=-1
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}